Reporters.io
Mike Bassett
MedPage Today
Profile
Contacts
Recent Articles on Subject
1
Mike Bassett
MedPage Today
Explains healthcare complexities. Not endorsements.
New York, New York
Healthcare journalism
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma
- 3 days ago
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC
- 5 days ago
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
- 12 days ago
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
- 12 days ago
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
- 25 days ago
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer
- 27 days ago
Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer
- about 1 month ago
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
- about 2 months ago
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor
- about 2 months ago
EHR 'Nudge' Cut Low-Value Surgery Rates in Older Breast Cancer Patients
- 2 months ago
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
- 2 months ago
Mediterranean Diet Tied to Lower Mortality Risk in Cancer Survivors
- 2 months ago
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
- 2 months ago
Most Women Can Have Successful Pregnancies After Breast Cancer Treatment
- 4 months ago
Blood Test for Colon Cancer Screening Secures FDA Panel's Blessing
- 4 months ago
HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer
- 5 months ago
Journey Into Virtual Reality Eases Cancer Pain
- 5 months ago
Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis
- 5 months ago
Novel PARP1 Inhibitor Shows Promise in Breast Cancer
- 5 months ago
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?
- 5 months ago
Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials
- 5 months ago
PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening
- 5 months ago
More Bird Flu Spread; FDA to Allow Gay Men to Donate Sperm; 'Oatzempic' Trend
- 5 months ago
Chemotherapy/ICI Combos Falter as Second-Line Treatment for Gastric Cancer
- 6 months ago
Evidence Strengthens for De-Escalating Axillary Surgery in Breast Cancer
- 6 months ago
PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphoma
- 6 months ago
Liquid Biopsy for CRC Screening May Not Be Ready for Prime Time
- 6 months ago
Rucaparib Maintenance Boosts PFS in Metastatic, Recurrent Endometrial Cancer
- 6 months ago
FDA Panel Endorses Imetelstat for MDS-Related Anemia
- 6 months ago
FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemia
- 6 months ago
First-Line Nivolumab Plus Chemo Approved for Bladder Cancer
- 6 months ago
First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests
- 6 months ago
A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu
- 6 months ago
Novel Therapy Promising for Radiation-Induced Oral Mucositis
- 7 months ago
Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results
- 7 months ago
Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriers
- 7 months ago
FDA Announces End to 'Forever Chemicals' in U.S. Food Packaging
- 7 months ago
FDA Approves Antibiotic Combination for Complicated UTIs
- 7 months ago
Male Fertility Problems in the Family Linked to Cancer Risk
- 7 months ago
Annual Breast Cancer Screening Starting at Age 40 Best, Modeling Study Says
- 7 months ago
FDA OKs First Cellular Therapy for Melanoma
- 7 months ago
Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC
- 7 months ago
Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant
- 7 months ago
New First-Line Option for Pancreatic Cancer Approved
- 7 months ago
Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation
- 7 months ago
Trader Joe's Food Alert; DEA Reverses Decision; Going Maskless Is Not Free Speech
- 7 months ago
All-Oral Therapy Promising in Higher-Risk MDS, CMML
- 7 months ago
Cabozantinib Plus Atezolizumab Delays Progression in mCRPC
- 8 months ago
No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer
- 8 months ago
Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone
- 8 months ago